<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1042">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04414657</url>
  </required_header>
  <id_info>
    <org_study_id>CTC HFV2</org_study_id>
    <nct_id>NCT04414657</nct_id>
  </id_info>
  <brief_title>USZ BioResource COVID</brief_title>
  <official_title>Development of a SARS-CoV-2 Research Biobank</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Regina Grossmann</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Zurich</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Mono-centric. Blood sampling for biobank development, including linkage to patient data
      (resource for research on COVID19).
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 9, 2020</start_date>
  <completion_date type="Anticipated">April 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">April 30, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>blood sampling for biobank</measure>
    <time_frame>2 years</time_frame>
    <description>development of a biobank</description>
  </primary_outcome>
  <enrollment type="Anticipated">500</enrollment>
  <condition>COVID19</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>blood sampling for biobank</intervention_name>
    <description>blood sampling for biobank</description>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      PBMCs
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        SARS-CoV-2 infektion (according to WHO guideline)
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  m/f age &gt; 18 years

          -  SARS-CoV-2 infektion (according to WHO guideline)

          -  hospitalisation, general ward

          -  acceptable language knowledge

          -  voluntary IFC and biobank appendix

        Exclusion Criteria:

          -  contra indication for blood sampling
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Regina Grossmann, Dr med</last_name>
    <role>Study Director</role>
    <affiliation>Head of Clinical Trials Center University Hospital Zurich</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Silke Ludwig, MSc</last_name>
    <phone>+41432530248</phone>
    <email>silke.ludwig@usz.ch</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Anja Eskat, PhD</last_name>
    <phone>+41432530266</phone>
    <email>Anja.Eskat@usz.ch</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Hospital Zurich, Clinical Trials Center</name>
      <address>
        <city>Zurich</city>
        <zip>8091</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Silke Ludwig, MSc</last_name>
      <phone>+41442530248</phone>
      <email>silke.ludwig@usz.ch</email>
    </contact>
    <contact_backup>
      <last_name>Anja Eskat, PhD</last_name>
      <phone>+41432530266</phone>
      <email>Anja.Eskat@usz.ch</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>June 2, 2020</study_first_submitted>
  <study_first_submitted_qc>June 2, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 4, 2020</study_first_posted>
  <last_update_submitted>June 2, 2020</last_update_submitted>
  <last_update_submitted_qc>June 2, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 4, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Zurich</investigator_affiliation>
    <investigator_full_name>Regina Grossmann</investigator_full_name>
    <investigator_title>Dr. med.</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

